2-amino-N-(3,4-dimethoxyphenethyl)benzamide | 125232-06-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-amino-N-(3,4-dimethoxyphenethyl)benzamide
• 英文别名: 2-amino-N-[2-(3,4-dimethoxyphenyl)ethyl]benzamide
• CAS: 125232-06-6
• 化学式: C₁₇H₂₀N₂O₃
• mdl: MFCD00115978
• 分子量: 300.357
• InChiKey: HNRBTBTZWBBYGN-UHFFFAOYSA-N

物化性质

• 熔点：
  107 °C(Solv: ligroine (8032-32-4))
• 沸点：
  519.9±50.0 °C(Predicted)
• 密度：
  1.167±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  22
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  73.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-amino-N-(3,4-dimethoxyphenethyl)benzamide 在 copper(ll) sulfate pentahydrate 、 potassium carbonate 、 sodium ascorbate 、 potassium hydroxide 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 32.0h， 生成 3-(3,4-dimethoxyphenethyl)-2-(((1-(4-fluorobenzyl)-1H-1,2,3-triazol-4-yl)methyl)thio) quinazolin-4(3H)-one
  参考文献：
  名称：

  Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study

  摘要：

  A novel series of quinazolinone-1,2,3-triazole hybrids 10a-p were designed, synthesized, and evaluated for their in vitro alpha-glucosidase inhibitory activity leading to efficient anti-diabetic agents. All synthesized compounds exhibited good inhibitory activity against yeast alpha-glucosidase (IC50 values in the range of 181.0-474.5 mu M) even much more potent than standard drug acarbose (IC50 = 750.0). Among them, quinazolinone-1,2,3-triazoles possessing 4-bromobenzyl moiety connected to 1,2,3-triazole ring (10g and 10p) demonstrated the most potent inhibitory activity towards alpha-glucosidase. Compound 10g inhibited alpha-glucosidase in a competitive manner with K-i value of 117 mu M. Furthermore, the binding modes of the most potent compounds 10g and 10p in the alpha-aglucosidase active site was studied through in silico docking studies. Also, lack of cytotoxicity of compounds 10g and 10p was confirmed via MTT assay.

  DOI：

  10.1016/j.bioorg.2018.10.023
• 作为产物：
  描述：

  6-Nitro-benzo[1,3]dioxole-5-carboxylic acid [2-(3,4-dimethoxy-phenyl)-ethyl]-amide 以11%的产率得到
  参考文献：
  名称：

  JOSHI, VIDYA;CHAUDHARI, R. P.;MOGERA, S. R., INDIAN J. CHEM. B, 28,(1989) N, C. 431-434

  摘要：

  DOI：

文献信息

• Structural optimization of natural product nordihydroguaretic acid to discover novel analogues as AcrB inhibitors
  作者：Yinhu Wang、Rawaf Alenzy、Di Song、Xingbang Liu、Yuetai Teng、Rumana Mowla、Yingang Ma、Steven W. Polyak、Henrietta Venter、Shutao Ma

  DOI：10.1016/j.ejmech.2019.111910

  日期：2020.1

  targets. Herein, we present initial chemical optimization and structure-activity relationship (SAR) data around a previously described efflux pump inhibitor, nordihydroguaretic acid (NDGA). Four series of novel NDGA analogues that target Escherichia coli AcrB were designed, synthesized and evaluated for their ability to potentiate the activity of antibiotics, to inhibit AcrB-mediated substrate efflux

  药物外排泵对危险的细菌病原体具有多重耐药性，这使这些蛋白质成为有希望的药物靶标。在本文中，我们围绕先前描述的外排泵抑制剂降冰片二氢乙酸（NDGA）提出了初始化学优化和结构-活性关系（SAR）数据。设计，合成和评估了针对大肠杆菌AcrB的四个系列的新型NDGA类似物，以评估它们增强抗生素活性，抑制AcrB介导的底物外流并降低脱靶活性的能力。鉴定出九种新颖结构，这些结构提高了一组抗生素的功效，抑制了药物外排并降低了细菌外膜和内膜的通透性。其中，WA7，具有广谱抗菌增敏活性的WB11和WD6被鉴定为具有良好特性的NDGA类似物，可作为潜在的AcrB抑制剂，与NDGA相比，其效能有中等程度的提高。尤其是，WD6是最广泛活性的类似物，可提高所有四类抗菌药物的活性。
• Synthesis, Anti-microbial and Molecular Docking Studies of Quinazolin-4(3H)-one Derivatives
  作者：Yahia Mabkhot、Munirah Al-Har、Assem Barakat、Fahad Aldawsari、Ali Aldalbahi、Zaheer Ul-Haq

  DOI：10.3390/molecules19078725

  日期：——

  In this work, synthesis, antimicrobial activities and molecular docking studies of some new series of substituted quinazolinone 2a–h and 3a–d were described. Starting form 2-aminobenzamide derivatives 1, a new series of quinazolinone derivatives has been synthesized, in high yields, assisted by microwave and classical methods. Some of these substituted quinazolinones were tested for their antimicrobial activity against Gram-negative bacteria (Pseudomonas aeruginosa and Esherichia coli) and Gram-positive bacteria (Staphylococcus aureus, and Bacillus subtilis), and anti-fungal activity against (Aspergillus fumigatus, Saccharomyces cervevisiae, and Candida albicans) using agar well diffusion method. Among the prepared products, 3-benzyl-2-(4-chlorophenyl)quinazolin-4(3H)-one (3a) was found to exhibits the most potent in vitro anti-microbial activity with MICs of 25.6 ± 0.5, 24.3 ± 0.4, 30.1 ± 0.6, and 25.1 ± 0.5 µg/mL against Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa and Esherichia coli, respectively. Compound 3a was found to exhibits the most potent in vitro anti-fungal activity with MICs of 18.3 ± 0.6, 23.1 ± 0.4, and 26.1 ± 0. 5 µg/mL against Aspergillus fumigatus, Saccharomyces cervevisiae, and Candidaal bicans, respectively.

  在这项工作中，描述了一些新的取代喹唑啉酮2a–h和3a–d的合成、抗微生物活性及分子对接研究。从2-氨基苯甲酰胺衍生物1出发，通过微波辅助和经典方法，高效合成了一系列喹唑啉酮衍生物。其中一些取代喹唑啉酮通过琼脂孔扩散法测试了它们对革兰氏阴性菌（铜绿假单胞菌和大肠杆菌）和革兰氏阳性菌（金黄色葡萄球菌和枯草芽孢杆菌）以及抗真菌活性（烟曲霉、酿酒酵母和白色念珠菌）的抗微生物活性。在制备的产品中，3-苄基-2-(4-氯苯基)喹唑啉-4(3H)-酮（3a）表现出最强的体外抗微生物活性，对金黄色葡萄球菌、枯草芽孢杆菌、铜绿假单胞菌和大肠杆菌的MIC值分别为25.6 ± 0.5、24.3 ± 0.4、30.1 ± 0.6和25.1 ± 0.5 µg/mL。化合物3a还表现出最强的体外抗真菌活性，对烟曲霉、酿酒酵母和白色念珠菌的MIC值分别为18.3 ± 0.6、23.1 ± 0.4和26.1 ± 0.5 µg/mL。
• Convenient and sequential one-pot route for synthesis of 2-thioxoquinazolinone and quinazolinobenzothiazinedione derivatives
  作者：Mehdi Asadi、Shiva Masoomi、Seyed Mostafa Ebrahimi、Mohammad Mahdavi、Mina Saeedi、Abbas Shafiee、Alireza Foroumadi

  DOI：10.1007/s00706-013-1110-8

  日期：2014.3

  AbstractA new and efficient synthetic process has been developed for preparation of 2-thioxoquinazolinone and quinazolinobenzothiazinedione derivatives. The related products were synthesized through reaction of isatoic anhydride, amines/anthranilic acids, and carbon disulfide (CS2) in the presence of potassium hydroxide in ethanol at reflux. Graphical abstract

  摘要已经开发出一种新的有效的合成方法来制备2-硫代氧杂喹唑啉酮和喹唑啉基苯并噻嗪二酮衍生物。在乙醇中，在氢氧化钾存在下，通过等角酸酐，胺/邻氨基苯甲酸和二硫化碳（CS 2）反应合成相关产物。 图形概要
• An efficient one pot synthesis of 2-amino quinazolin-4(3 H )-one derivative via MCR strategy
  作者：V. Narayana Murthy、Satish P. Nikumbh、S. Praveen Kumar、L. Vaikunta Rao、Akula Raghunadh

  DOI：10.1016/j.tetlet.2015.08.040

  日期：2015.10

  multi-component reaction strategy was developed for the construction of important building blocks, 2-amino 3-substituted quinazolinone derivatives from isatoic anhydride and amine with electrophilic cyanating compound, N-cyano-4-methyl-N-phenylbenzenesulfonamide (NCTS). The quinazolinone synthesis proceeds via a sequential series of reactions such as nucleophilic attack of the amine group on the carbonyl group

  开发了一种新颖的多组分反应策略，用于构造重要的结构单元，由异酸酐和胺与亲电子氰化化合物，N-氰基-4-甲基-N-苯基苯磺酰胺（NCTS）合成的2-氨基3-取代的喹唑啉酮衍生物。喹唑啉酮的合成是通过一系列连续的反应进行的，例如胺基对等酸酐的羰基的亲核攻击，然后开环和随后的脱羧，胺对腈的亲核攻击，然后杂环化。
• Novel quinazolin–sulfonamid derivatives: synthesis, characterization, biological evaluation, and molecular docking studies
  作者：Nima Sepehri、Maryam Mohammadi-Khanaposhtani、Nafise Asemanipoor、Samanesadat Hosseini、Mahmood Biglar、Bagher Larijani、Mohammad Mahdavi、Haleh Hamedifar、Parham Taslimi、Nastaran Sadeghian、Mostafa Norizadehtazehkand、Ilhami Gulcin

  DOI：10.1080/07391102.2020.1847193

  日期：2022.5.24

  In the design of novel drugs, the formation of hybrid molecules via the combination of several pharmacophores can give rise to compounds with interesting biochemical profiles. A series of novel quinazolin–sulfonamid derivatives (9a–m) were synthesized, characterized and evaluated for their in vitro antidiabetic, anticholinergics, and antiepileptic activity. These synthesized novel quinazolin–sulfonamid

  摘要 在新药的设计中，通过几种药效团的组合形成杂合分子可以产生具有有趣生化特征的化合物。合成、表征和评估了一系列新型喹唑啉-磺胺衍生物 ( 9a-m )的体外抗糖尿病、抗胆碱能和抗癫痫活性。这些合成的新型喹唑啉-磺胺衍生物（9a-m) 被发现是 α-糖苷酶、人碳酸酐酶 I 和 II (hCA I 和 hCA II)、丁酰胆碱酯酶 (BChE) 和乙酰胆碱酯酶 (AChE) 酶的有效抑制剂分子，Ki 值范围为 100.62 ± 13.68– α-糖苷酶为 327.94 ± 58.21 nM，hCA I 为 1.03 ± 0.11–14.87 ± 2.63 nM，hCA II 为 1.83 ± 0.24–15.86 ± 2.57 nM，BChE 为 30.12 ± 3.81–102.16 ± 13.87 nM，和 26..15–8 ± 3对于 AChE，分别为 ± 20.11 nM。在最后一步